RSS   Newsletter   Contact   Advertise with us
Post Online Media

Cipher Pharmaceuticals names Stephen L. Lemieux interim CEO

Cipher PharmaceuticalsCipher Pharmaceuticals, a clinical stage biotechnology company, announced that Stephen L. Lemieux, CFO and secretary of the company, has been named interim CEO.
Article continues below

READ MORE Cipher appoints William Claypool to board of directors

Mr. Lemieux will also continue in the role as Chief Financial Officer and Secretary of the Company during this interim period.

Prior to joining Cipher, Mr. Lemieux served as Vice President and Chief Financial Officer of Nuvo Pharmaceuticals.

Prior to joining Nuvo in 2007, Mr. Lemieux held multiple senior financial positions, including Corporate Controller at Martinrea International Inc., a Tier One automotive supplier, and Assistant Controller at Magna Powertrain.

Mr. Lemieux also worked for Ernst & Young performing audit, restructuring and accounting work for its clients.

He is a Chartered Professional Accountant and holds a Master of Management & Professional Accounting from the University of Toronto.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy